.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts
Colorcon
Merck
Deloitte
Boehringer Ingelheim
Cipla
Novartis
Moodys
McKesson

Generated: July 24, 2017

DrugPatentWatch Database Preview

Polyethylene glycol 3350 - Generic Drug Details

« Back to Dashboard

What are the generic sources for polyethylene glycol 3350 and what is the scope of polyethylene glycol 3350 freedom to operate?

Polyethylene glycol 3350
is the generic ingredient in twenty-two branded drugs marketed by Kremers Urban Pharms, Nuvo Pharm Inc, Nexgen Pharma Inc, Nexgen Pharma, Par Pharm, Bayer Healthcare Llc, Mylan, Strides Pharma, Breckenridge Pharm, Teva Pharms, Ani Pharms Inc, Paddock Llc, Raritan Pharms Inc, Novel Labs Inc, Perrigo R And D, Mylan Pharms Inc, Braintree, Hospira, Goldline, Dynapharm, Vintage Pharms, E Z Em, Mylan Speciality Lp, and Sandoz, and is included in thirty-eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four hundred and eighteen drug master file entries for polyethylene glycol 3350. Seventy-three suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: polyethylene glycol 3350

Tradenames:22
Patents:1
Applicants:24
NDAs:38
Drug Master File Entries: see list418
Suppliers / Packagers: see list73
Bulk Api Vendors: see list244
Clinical Trials: see list265
Patent Applications: see list4,412
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:polyethylene glycol 3350 at DailyMed

Pharmacology for Ingredient: polyethylene glycol 3350

Tentative approvals for POLYETHYLENE GLYCOL 3350

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe2MG; 5MGSOLUTION; ORAL AND TABLET; DELAYED RELEASE
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc
POLYETHYLENE GLYCOL 3350
polyethylene glycol 3350
FOR SOLUTION;ORAL077893-001May 26, 2006AARXNoNo► Subscribe► Subscribe► Subscribe
E Z Em
E-Z-EM PREP LYTE
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous
FOR SUSPENSION;ORAL071278-001Nov 21, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Nexgen Pharma Inc
POLYETHYLENE GLYCOL 3350
polyethylene glycol 3350
FOR SOLUTION;ORAL077706-001Sep 27, 2006AARXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
PEG-LYTE
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous
FOR SUSPENSION;ORAL073098-001Aug 31, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
PEG 3350 AND ELECTROLYTES
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous
FOR SOLUTION;ORAL090186-001Jun 1, 2009AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
UBS
Cipla
Medtronic
McKesson
Fish and Richardson
Cerilliant
Teva
Merck
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot